Search results
GSK shares fall 9% in wake of Zantac court ruling
Pharmaceutical Technology via Yahoo Finance· 12 hours agoZantac was launched in 1988 and became one of the first-ever drugs to reach over $1bn in yearly sales. It was one of GSK’s top products and was later...
A club drug could be the next big thing in treating mental illness
Politico via Yahoo News· 9 hours agoPatients reported getting addicted to the drug as well as bladder damage. MDMA comes with its own health risks, including heart problems. In its initial ...
1 Beaten-Down S&P 500 Dividend Stock to Buy in June and Hold For a Decade or Longer
Motley Fool via Yahoo Finance· 14 hours agoOne of those therapies, Padcev, recently earned approval from the Food and Drug Administration (FDA)...
Gilead drug fails to confirm its FDA approval in bladder cancer - Silicon Valley Business Journal
The Business Journals· 4 days agoMore patients in the trial who were on the drug — one of the core drugs in the Foster City company's...
Gilead's Trodelvy fails to meet main goal in late-stage cancer study
Reuters via AOL· 5 days agoShares of Gilead fell 3.3% in extended trade after the company said the drug did not meet the main...
BMS secures another EC approval for Opdivo combination
Pharmaceutical Technology via Yahoo Finance· 6 days agoAstraZeneca is investigating its checkpoint inhibitor Imfinzi (durvalumab) in combination with...
Is Moderna Stock A Buy As The U.S. Government Mulls Its Bird Flu Vaccine?
Investor's Business Daily· 4 days agoMeanwhile, investors are closely watching for Food and Drug Administration approval of Moderna's RSV...
Nubeqa: Mild to serious side effects and how to manage them
Medical News Today· 1 day agoNubeqa (darolutamide) is a brand-name oral tablet prescribed for certain types of prostate cancer in...
Gilead’s Trodelvy misses goal in bladder cancer study
BioPharma Dive via Yahoo Finance· 5 days agoTreatment didn’t significantly improve overall survival in the trial, a finding that one analyst...
Moderna, Merck say vaccine improved survival in patients with deadly skin cancer
CNBC· 1 day agoModerna and Merck released more positive three-year data Monday on their experimental vaccine, given...